CONTEXT: The positive association of elevated fibroblast growth factor-23 (FGF23) with PTH levels in the setting of secondary hyperparathyroidism is paradoxical to the purported effects of FGF23 to suppress PTH secretion. OBJECTIVE: We used dynamic calcium-mediated suppression of PTH levels in hemodialysis (HD) patients to determine the relationship between FGF23 levels and parathyroid gland function. DESIGN: HD patients with elevated PTH were washed out of vitamin D analogs and/or calcimimetics and then exposed them to a high-calcium dialysate bath designed to suppress PTH. SETTING: The study was conducted at an outpatient HD unit of an academic medical center. PARTICIPANTS: Eighteen maintenance HD patients with elevated PTH levels participated in the study. MAIN OUTCOME MEASURES: Ionized calcium (iCa), PTH, and FGF23 levels were measured during HD. The slope of the relationship between iCa and PTH (a marker of parathyroid gland mass) and the iCa level required for a 50% reduction in PTH were determined, and the association of these with FGF23 levels was determined. RESULTS: Increased baseline log FGF23 levels were associated with putative alterations in gland mass as estimated by significantly shallower slopes of the iCa/PTH suppression curves (P = 0.0004), but there was no association between FGF23 and calcium sensing as measured by ionized Ca associated with a 50% suppression of PTH (P = 0.38). FGF23 levels decreased significantly during HD, but this change was not correlated with decrements in either renal phosphate or PTH. CONCLUSIONS: High FGF23 levels may be a marker for parathyroid gland hyperplasia in HD patients. Acute reductions in neither PTH nor renal phosphate during dialysis correlated with PTH suppression.
CONTEXT: The positive association of elevated fibroblast growth factor-23 (FGF23) with PTH levels in the setting of secondary hyperparathyroidism is paradoxical to the purported effects of FGF23 to suppress PTH secretion. OBJECTIVE: We used dynamic calcium-mediated suppression of PTH levels in hemodialysis (HD) patients to determine the relationship between FGF23 levels and parathyroid gland function. DESIGN:HDpatients with elevated PTH were washed out of vitamin D analogs and/or calcimimetics and then exposed them to a high-calcium dialysate bath designed to suppress PTH. SETTING: The study was conducted at an outpatientHD unit of an academic medical center. PARTICIPANTS: Eighteen maintenance HDpatients with elevated PTH levels participated in the study. MAIN OUTCOME MEASURES: Ionizedcalcium (iCa), PTH, and FGF23 levels were measured during HD. The slope of the relationship between iCa and PTH (a marker of parathyroid gland mass) and the iCa level required for a 50% reduction in PTH were determined, and the association of these with FGF23 levels was determined. RESULTS: Increased baseline log FGF23 levels were associated with putative alterations in gland mass as estimated by significantly shallower slopes of the iCa/PTH suppression curves (P = 0.0004), but there was no association between FGF23 and calcium sensing as measured by ionized Ca associated with a 50% suppression of PTH (P = 0.38). FGF23 levels decreased significantly during HD, but this change was not correlated with decrements in either renal phosphate or PTH. CONCLUSIONS: High FGF23 levels may be a marker for parathyroid gland hyperplasia in HDpatients. Acute reductions in neither PTH nor renal phosphate during dialysis correlated with PTH suppression.
Authors: E G Nabel; Z Y Yang; G Plautz; R Forough; X Zhan; C C Haudenschild; T Maciag; G J Nabel Journal: Nature Date: 1993-04-29 Impact factor: 49.962
Authors: Rocío Canalejo; Antonio Canalejo; Julio Manuel Martinez-Moreno; M Encarnacion Rodriguez-Ortiz; Jose C Estepa; Francisco Javier Mendoza; Juan Rafael Munoz-Castaneda; Victoria Shalhoub; Yolanda Almaden; Mariano Rodriguez Journal: J Am Soc Nephrol Date: 2010-04-29 Impact factor: 10.121
Authors: Shiguang Liu; Rong Guo; Leigh G Simpson; Zhou-Sheng Xiao; Charles E Burnham; L Darryl Quarles Journal: J Biol Chem Date: 2003-07-21 Impact factor: 5.157
Authors: Mara Riminucci; Michael T Collins; Neal S Fedarko; Natasha Cherman; Alessandro Corsi; Kenneth E White; Steven Waguespack; Anurag Gupta; Tamara Hannon; Michael J Econs; Paolo Bianco; Pamela Gehron Robey Journal: J Clin Invest Date: 2003-09 Impact factor: 14.808
Authors: Yenong Cao; Samirah A Gomes; Erika B Rangel; Ellena C Paulino; Tatiana L Fonseca; Jinliang Li; Marilia B Teixeira; Cecilia H Gouveia; Antonio C Bianco; Michael S Kapiloff; Wayne Balkan; Joshua M Hare Journal: J Clin Invest Date: 2015-03-23 Impact factor: 14.808
Authors: Adrian Covic; Jutta Passlick-Deetjen; Miroslaw Kroczak; Beatrix Büschges-Seraphin; Adrian Ghenu; Pedro Ponce; Barbara Marzell; Angel L M de Francisco Journal: Nephrol Dial Transplant Date: 2013-06-19 Impact factor: 5.992
Authors: Birgitte Nygaard; Niels Erik Frandsen; Lisbet Brandi; Knud Rasmussen; Ove Vyff Oestergaard; Lars Oedum; Hans Christian Hoeck; Ditte Hansen Journal: PLoS One Date: 2014-08-28 Impact factor: 3.240
Authors: Cristian Rodelo-Haad; Maria E Rodríguez-Ortiz; Alejandro Martin-Malo; M Victoria Pendon-Ruiz de Mier; M Luisa Agüera; Juan R Muñoz-Castañeda; Sagrario Soriano; Francisco Caravaca; M Antonia Alvarez-Lara; Arnold Felsenfeld; Pedro Aljama; Mariano Rodriguez Journal: PLoS One Date: 2018-08-07 Impact factor: 3.240